UK markets closed
NIKKEI 225
38,835.10 +599.03 (+1.57%) HANG SENG
18,479.37 -98.93 (-0.53%) CRUDE OIL
78.47 -0.01 (-0.01%) GOLD FUTURES
2,323.70 -7.50 (-0.32%) DOW
38,865.69 +13.42 (+0.03%) Bitcoin GBP
50,463.59 +244.77 (+0.49%)
CytomX Therapeutics, Inc. (CTMX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 03:17PM EDT. Market open.
| Previous close | 4.3700 |
| Open | 4.4500 |
| Bid | 4.2900 x 100 |
| Ask | 4.3200 x 100 |
| Day's range | 4.2100 - 4.4900 |
| 52-week range | 1.0400 - 5.8500 |
| Volume | |
| Avg. volume | 4,848,847 |
| Market cap | 292.992M |
| Beta (5Y monthly) | 1.02 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
CytomX Therapeutics (CTMX) Surges 214.7%: Is This an Indication of Further Gains?
CytomX Therapeutics (CTMX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
- Simply Wall St.
Here's Why We're Not Too Worried About CytomX Therapeutics' (NASDAQ:CTMX) Cash Burn Situation
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- Simply Wall St.
CytomX Therapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
CytomX Therapeutics ( NASDAQ:CTMX ) Full Year 2023 Results Key Financial Results Revenue: US$101.2m (up 90% from FY...
© 2024 Yahoo. All rights reserved.